Heranba Industries Ltd
BSE:543266
Heranba Industries Ltd
Heranba Industries Ltd. engages in the manufacture and marketing of a range of agrochemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 700 full-time employees. The company went IPO on 2021-03-05. The firm manufactures intermediates, technicals and formulations. The company produces synthetic pyrethroids, such as cypermethrin, alphacypermethrin, deltamethrin, permitherin, lambda cyhalothrin etc. Its business verticals include Domestic Institutional sales of Technicals, which is engaged in manufacturing and selling of technicals in bulk to domestic companies; Technicals Exports, which is engaged in exports of technicals in bulk to customers outside India; Branded Formulations focused on manufacturing and selling of formulations; Formulations Exports, which is engaged in export of formulations in bulk and customer specified packaging outside India, and Public Health, which is focused on manufacturing and selling of general insect control chemicals by participating in public health tenders issued by governmental authorities and selling to pest management companies.
Heranba Industries Ltd. engages in the manufacture and marketing of a range of agrochemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 700 full-time employees. The company went IPO on 2021-03-05. The firm manufactures intermediates, technicals and formulations. The company produces synthetic pyrethroids, such as cypermethrin, alphacypermethrin, deltamethrin, permitherin, lambda cyhalothrin etc. Its business verticals include Domestic Institutional sales of Technicals, which is engaged in manufacturing and selling of technicals in bulk to domestic companies; Technicals Exports, which is engaged in exports of technicals in bulk to customers outside India; Branded Formulations focused on manufacturing and selling of formulations; Formulations Exports, which is engaged in export of formulations in bulk and customer specified packaging outside India, and Public Health, which is focused on manufacturing and selling of general insect control chemicals by participating in public health tenders issued by governmental authorities and selling to pest management companies.
Revenue Growth: Heranba posted 9-month FY25 revenue of INR 1,075 crores, up from INR 1,000 crores last year, despite a tough environment.
Margin Pressure: EBITDA margin for 9M FY25 dropped to 11% due to lower product realizations and higher expenses. Gross margin declined 200–300 bps year-over-year.
Profit Increase: Profit after tax for 9M FY25 rose to INR 44 crores from INR 35 crores in the previous year.
CapEx Progress: New facilities at Sarigam and Saykha are coming online; both expected to start full commercial production by March 2025.
Pricing Recovery: After significant export-led price declines in Q3, management reports prices are stabilizing and improving in Q4.
Guidance Raised: Company expects FY26 revenue of INR 1,850–1,950 crores, with EBITDA margin of 12–14% and net margin of 5–6%.
Volume Growth: 9M FY25 volume growth was approximately 3–4%.
Utilization Rates: Existing plant at 85% utilization; new sites still ramping up.
